Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Samir H. Mody"'
Autor:
Guillaume Germain, François Laliberté, Brahim Bookhart, Edith A. Nutescu, Joseph F. Dasta, Patrick Lefebvre, Dominic Pilon, Samir H. Mody, Jessica Lopatto
Publikováno v:
Journal of Medical Economics. 18:1041-1049
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in the US, with an estimated prevalence of 2.7-6.1 million persons in 2010.This study evaluates the progression of daily hospitalization costs among non-valvular atrial fibrillati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99624522b6a0dbf4c76b821fd78371b1
https://doi.org/10.3111/13696998.2015.1074583
https://doi.org/10.3111/13696998.2015.1074583
Autor:
Jessica Lopatto, Dominic Pilon, Samir H. Mody, Joseph F. Dasta, Edith A. Nutescu, Brahim Bookhart, Patrick Lefebvre, Franc¸ois Laliberté, Guillaume Germain
Publikováno v:
Thrombosis Research. 135:303-310
Background Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), affects about 900,000 persons in the United States each year. Objectives To quantify the progression of daily hospitalization costs among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84923f34625eacc257679799e3d8a0f8
https://doi.org/10.1016/j.thromres.2014.11.024
https://doi.org/10.1016/j.thromres.2014.11.024
Publikováno v:
Journal of Medical Economics. 18:323-332
Venous thromboembolism (VTE) impacts ∼900,000 individuals annually in the US, causing up to 100,000 deaths. Patients experiencing VTE have heightened risk of recurrence. Initial parenteral anti-coagulation is standard therapy for acute VTE followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ef0f0599d8b4e7c8b62408988cb10c
https://doi.org/10.3111/13696998.2014.1001850
https://doi.org/10.3111/13696998.2014.1001850
Publikováno v:
Population Health Management. 17:372-387
Between 2002 and 2007, the nonmedical use of prescription pain relievers grew from 11.0 million to 12.5 million people in the United States. Societal costs attributable to prescription opioid abuse were estimated at $55.7 billion in 2007. The purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe6c5d3b7f9b8fba3f0e69e682aea73
https://doi.org/10.1089/pop.2013.0098
https://doi.org/10.1089/pop.2013.0098
Publikováno v:
Journal of Medical Economics. 17:691-695
Venous thromboembolism (VTE) (deep vein thrombosis [DVT] and pulmonary embolism [(PE]) represents a substantial economic burden to the healthcare system. Using data from the randomized EINSTEIN DVT and PE trials, this North American sub-group analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf39f7d951f77576f43bd7c4d893a6ab
https://doi.org/10.3111/13696998.2014.946993
https://doi.org/10.3111/13696998.2014.946993
Autor:
Brahim Bookhart, Joseph Menzin, Kathleen Lang, Jeff Schein, Aarti A Patel, Samir H. Mody, Michael Munsell
Publikováno v:
Journal of Thrombosis and Thrombolysis
The objective of this study was to assess deep vein thrombosis and pulmonary embolism (DVT/PE) recurrence rates and resource utilization among patients with an initial DVT or PE event across multiple payer perspectives. Retrospective analyses were pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa380d04d0bbdb5f8a82ba75767abd45
https://doi.org/10.1007/s11239-014-1108-z
https://doi.org/10.1007/s11239-014-1108-z
Autor:
Craig I Coleman, Edith A. Nutescu, Daisy Y. Zhuo, Si-Tien Wang, Kevin N. Tran, Lynn Huynh, Samir H. Mody, Patrick Lefebvre, Brahim Bookhart
Publikováno v:
Journal of Medical Economics. 17:52-64
Venous thromboembolism (VTE), comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE), is commonly treated with a low-molecular-weight heparin such as enoxaparin plus a vitamin K antagonist (VKA) to prevent recurrence. Administration of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::897dca67e800f36bc0e3f8b5e0b0aa4a
https://doi.org/10.3111/13696998.2013.858634
https://doi.org/10.3111/13696998.2013.858634
Autor:
G. Vorsanger, Myoung Kim, Wing Chow, Bill H. McCarberg, Carla L. Zema, Carmela Benson, Samir H. Mody, Aarti A Patel
Publikováno v:
Journal of Opioid Management. 9:401-406
Objective: To evaluate differences among physician specialties in the management of acute pain including prescribing practices and management of opioid-related side effects. Design and participants: The Physicians Partnering Against Pain (P 3 ) surve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77be750b85d0287a4f9e2d52f8e106cc
https://doi.org/10.5055/jom.2013.0182
https://doi.org/10.5055/jom.2013.0182
Publikováno v:
Journal of Medical Economics. 16:307-317
To evaluate costs and outcomes associated with initial tapentadol ER vs oxycodone CR for the treatment of chronic non-cancer pain (CNCP) in the US.This study developed a Monte-Carlo simulation based on the scientific foundation established by publish
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ca4dbd4dfe06a538fadb5d52448f28
https://doi.org/10.3111/13696998.2012.756401
https://doi.org/10.3111/13696998.2012.756401
Autor:
C. Chen, Alan C. Fisher, Jerrold Hill, Gregory P. Hess, Monika Raut, Jeff Schein, Samir H. Mody
Publikováno v:
Advances in Therapy
Introduction| Antibiotic treatment failure contributes to the economic and humanistic burdens of community-acquired pneumonia (CAP) by increasing morbidity, mortality, and healthcare costs. This study compared treatment failure rates of levofloxacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97baedf89663e6aad5f303d11c711de3
https://doi.org/10.1007/s12325-010-0062-1
https://doi.org/10.1007/s12325-010-0062-1